CILcare is pleased to announce that our Global Head of R&D Operations Management, Aurore Marie, will present the latest advances on ototoxicity during the CBSET Talking Tox Webinar as part…
Montpellier, November 8th, 2021: CILcare, the world leading CRO specialized in hearing disorders, is proud to announce it has been awarded the ISO 9001:2015 certification for its quality management system…
Montpellier, November 09th 2020 – CILcare, a world leading CRO entirely dedicated to ear disorders, announces today the opening of a new subsidiary in Copenhagen, Denmark. Already established in the…
In collaboration with ENT Clinical, we present the webinar: Key success criteria for hearing (pre)clinical trials November 12, 2020 - 18:00 CET We are pleased to announce that this…
CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category Montpellier, France —  September 30, 2020  — CILcare,…
Montpellier, September 3rd, 2020: CILcare, world leading CRO specialized in the field of hearing, announced today that Dr. Marie-Pierre PASDELOU, CILcare’s co-founder and current Chief Development Officer, is taking over…
Issued in World Pharma Today, August 24, 2020 As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find…
Issued in World Pharma Today, August 24, 2020 As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find…
